Edition:
United Kingdom

Aquestive Therapeutics Announces U.S. FDA Acceptance Of New Drug Application For ALS Oral Treatment


Tuesday, 16 Apr 2019 

April 16 (Reuters) - Aquestive Therapeutics Inc ::AQUESTIVE THERAPEUTICS ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION (FDA) ACCEPTANCE OF NEW DRUG APPLICATION FOR RILUZOLE ORAL FILM FOR TREATMENT OF ALS.AQUESTIVE THERAPEUTICS INC - PDUFA (PRESCRIPTION DRUG USER FEE ACT) GOAL DATE IS NOVEMBER 30, 2019.AQUESTIVE THERAPEUTICS INC - COMPANY IS EXPLORING COMMERCIAL OPPORTUNITIES FOR ROF IN U.S. AND ABROAD.. 

Company Quote

4.23
-0.28 -6.21%
24 May 2019